Market Estimates
Valuation Metrics
Financials
Trading Trends
MGNX News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is MacroGenics Inc (MGNX) stock price today?
The current price of MGNX is 1.815 USD — it has increased 1.4 % in the last trading day.
What is MacroGenics Inc (MGNX)'s business?
MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its other product candidates are MGD024, retifanlimab, enoblituzumab, and vobramitamab duocarmazine. MGD024 is an investigational, next-generation, bispecific CD123 CD3 DART molecule designed to engage CD3 expressed on immune effector cells, such as T cells.
What is the price predicton of MGNX Stock?
Wall Street analysts forecast MGNX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MGNX is 3.00 USD with a low forecast of 2.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is MacroGenics Inc (MGNX)'s revenue for the last quarter?
MacroGenics Inc revenue for the last quarter amounts to 72.84M USD, decreased -34.21 % YoY.
What is MacroGenics Inc (MGNX)'s earnings per share (EPS) for the last quarter?
MacroGenics Inc. EPS for the last quarter amounts to 0.27 USD, decreased -70.00 % YoY.
What changes have occurred in the market's expectations for MacroGenics Inc (MGNX)'s fundamentals?
How many employees does MacroGenics Inc (MGNX). have?
MacroGenics Inc (MGNX) has 341 emplpoyees as of January 09 2026.
What is MacroGenics Inc (MGNX) market cap?
Today MGNX has the market capitalization of 113.23M USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F23a6fc0364a4d88da7c25c1effd7df2578795e9e8f4ec20dd557a19f134a87d1.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fnasdaq.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F94d79d4225583ada8df16d03783141bee29f43a740a3c9c934063c24f1b7e12a.jpeg&w=384&q=75)